ArticleOncotarget2018

A bi-specific inhibitor targeting IL-17A and MMP-9 reduces invasion and motility in MDA-MB-231 cells.

Dana Koslawsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.